Mimedx (MDXG) Total Debt Growth (1y) (2012 - 2026)
Mimedx (MDXG) Total Debt Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 103.99% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.84% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | -5.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.70% |
| Dec 31, 2025 | -4.58% |
| Sep 30, 2025 | -4.23% |
| Jun 30, 2025 | -9.72% |
| Mar 31, 2025 | -4.09% |
| Dec 31, 2024 | -60.85% |
| Sep 30, 2024 | -61.16% |
| Jun 30, 2024 | -58.13% |
| Mar 31, 2024 | -60.07% |
| Dec 31, 2023 | -1.02% |
| Sep 30, 2023 | 1.01% |
| Jun 30, 2023 | 1.00% |
| Mar 31, 2023 | 0.98% |
| Dec 31, 2022 | 0.97% |
| Sep 30, 2022 | -3.05% |
| Jun 30, 2022 | 0.94% |
| Mar 31, 2022 | -3.52% |
| Dec 31, 2021 | 0.90% |
| Sep 30, 2021 | 4.98% |
| Jun 30, 2021 | -36.74% |